Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Classical hematology 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 11Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia, Myeloid, Acute 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Mantle-Cell 6Leukemia, Myelomonocytic, Acute 6Leukemia, Monocytic, Acute 6Leukemia, Erythroblastic, Acute 6Congenital Abnormalities 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Leukemia, Megakaryoblastic, Acute 5Waldenstrom Macroglobulinemia 4Lymphoma, Non-Hodgkin 4Lymphoma, B-Cell, Marginal Zone 4Multiple Myeloma 3Lymphoma 3Leukemia, Prolymphocytic 3Burkitt Lymphoma 3Sezary Syndrome 2Prostatic Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Immunoblastic Lymphadenopathy 2

Interventions

Rituximab 5Cyclophosphamide 4fludarabine phosphate 3alvocidib 3Peripheral Blood Stem Cell Transplantation 3Sunitinib 2Pharmacogenomic Testing 2Lenalidomide 2Filgrastim 2Carboplatin 2tanespimycin 1sargramostim 1ofatumumab 1obatoclax 1laromustine 1dinaciclib 1cytokine inducible SH2-containing protein 1Vorinostat 1Vincristine 1Therapeutics 1Tacrolimus 1RFB4(dsFv)-PE38 recombinant immunotoxin 1Psychiatric Rehabilitation 1Prednisone 1Polymerase Chain Reaction 1Pentostatin 1Mycophenolic Acid 1Microarray Analysis 1Methotrexate 1MK 2206 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Leukemia, Prolymphocytic × alvocidib × Clear all
NCT00098371 2016-10-24

Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia

National Cancer Institute (NCI)

Phase 2 Terminated
64 enrolled 16 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

NCT01076556 2015-11-11

Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

National Cancer Institute (NCI)

Phase 1 Terminated
9 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

NCT00735930 2015-04-02

Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
39 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡